{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:25:26Z","timestamp":1773937526488,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,9,24]],"date-time":"2006-09-24T00:00:00Z","timestamp":1159056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,24]],"date-time":"2006-09-24T00:00:00Z","timestamp":1159056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1038\/nm1475","type":"journal-article","created":{"date-parts":[[2006,9,24]],"date-time":"2006-09-24T13:53:55Z","timestamp":1159106035000},"page":"1160-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":479,"title":["Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals"],"prefix":"10.1038","volume":"12","author":[{"given":"Ann M","family":"Leen","sequence":"first","affiliation":[]},{"given":"G Doug","family":"Myers","sequence":"additional","affiliation":[]},{"given":"Uluhan","family":"Sili","sequence":"additional","affiliation":[]},{"given":"M Helen","family":"Huls","sequence":"additional","affiliation":[]},{"given":"Heidi","family":"Weiss","sequence":"additional","affiliation":[]},{"given":"Kathryn S","family":"Leung","sequence":"additional","affiliation":[]},{"given":"George","family":"Carrum","sequence":"additional","affiliation":[]},{"given":"Robert A","family":"Krance","sequence":"additional","affiliation":[]},{"given":"Chung-Che","family":"Chang","sequence":"additional","affiliation":[]},{"given":"Jeffrey J","family":"Molldrem","sequence":"additional","affiliation":[]},{"given":"Adrian P","family":"Gee","sequence":"additional","affiliation":[]},{"given":"Malcolm K","family":"Brenner","sequence":"additional","affiliation":[]},{"given":"Helen E","family":"Heslop","sequence":"additional","affiliation":[]},{"given":"Cliona M","family":"Rooney","sequence":"additional","affiliation":[]},{"given":"Catherine M","family":"Bollard","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2006,9,24]]},"reference":[{"key":"BFnm1475_CR1","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","volume":"99","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti, S. et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 99, 4357\u20134363 (2002).","journal-title":"Blood"},{"key":"BFnm1475_CR2","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","volume":"100","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti, S. et al. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 100, 1619\u20131627 (2002).","journal-title":"Blood"},{"key":"BFnm1475_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.bbmt.2003.09.017","volume":"10","author":"CM Bollard","year":"2004","unstructured":"Bollard, C.M., Kuehnle, I., Leen, A., Rooney, C.M. & Heslop, H.E. Adoptive immunotherapy for posttransplantation viral infections. Biol. Blood Marrow Transplant. 10, 143\u2013155 (2004).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"BFnm1475_CR4","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","volume":"330","author":"EB Papadopoulos","year":"1994","unstructured":"Papadopoulos, E.B. et al. Infusions of donor leukocytes to treat Epstein-Barr virus\u2013associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185\u20131191 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1475_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJM199409083311017","volume":"331","author":"HE Heslop","year":"1994","unstructured":"Heslop, H.E., Brenner, M.K. & Rooney, C.M. Donor T cells to treat EBV-associated lymphoma. N. Engl. J. Med. 331, 679\u2013680 (1994).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1475_CR6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","volume":"92","author":"CM Rooney","year":"1998","unstructured":"Rooney, C.M. et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus\u2013induced lymphoma in allogeneic transplant recipients. Blood 92, 1549\u20131555 (1998).","journal-title":"Blood"},{"key":"BFnm1475_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038\u20131044 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm1475_CR8","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","volume":"99","author":"H Einsele","year":"2002","unstructured":"Einsele, H. et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 99, 3916\u20133922 (2002).","journal-title":"Blood"},{"key":"BFnm1475_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1126\/science.1352912","volume":"257","author":"SR Riddell","year":"1992","unstructured":"Riddell, S.R. et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257, 238\u2013241 (1992).","journal-title":"Science"},{"key":"BFnm1475_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1084\/jem.20040613","volume":"202","author":"M Cobbold","year":"2005","unstructured":"Cobbold, M. et al. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202, 379\u2013386 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1475_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","volume":"362","author":"KS Peggs","year":"2003","unstructured":"Peggs, K.S. et al. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines. Lancet 362, 1375\u20131377 (2003).","journal-title":"Lancet"},{"key":"BFnm1475_CR12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","volume":"95","author":"A Gustafsson","year":"2000","unstructured":"Gustafsson, A. et al. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. Blood 95, 807\u2013814 (2000).","journal-title":"Blood"},{"key":"BFnm1475_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm0596-551","volume":"2","author":"HE Heslop","year":"1996","unstructured":"Heslop, H.E. et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2, 551\u2013555 (1996).","journal-title":"Nat. Med."},{"key":"BFnm1475_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","volume":"102","author":"T Lion","year":"2003","unstructured":"Lion, T. et al. Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 102, 1114\u20131120 (2003).","journal-title":"Blood"},{"key":"BFnm1475_CR15","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","volume":"104","author":"AM Leen","year":"2004","unstructured":"Leen, A.M. et al. Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. Blood 104, 2432\u20132440 (2004).","journal-title":"Blood"},{"key":"BFnm1475_CR16","doi-asserted-by":"publisher","first-page":"6562","DOI":"10.1128\/JVI.77.11.6562-6566.2003","volume":"77","author":"B Heemskerk","year":"2003","unstructured":"Heemskerk, B. et al. Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J. Virol. 77, 6562\u20136566 (2003).","journal-title":"J. Virol."},{"key":"BFnm1475_CR17","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1084\/jem.194.12.1721","volume":"194","author":"Q Wang","year":"2001","unstructured":"Wang, Q., Strong, J. & Killeen, N. Homeostatic competition among T cells revealed by conditional inactivation of the mouse CD4 gene. J. Exp. Med. 194, 1721\u20131730 (2001).","journal-title":"J. Exp. Med."},{"key":"BFnm1475_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.micro.54.1.19","volume":"54","author":"R Khanna","year":"2000","unstructured":"Khanna, R. & Burrows, S.R. Role of cytotoxic T lymphocytes in Epstein-Barr virus\u2013associated diseases. Annu. Rev. Microbiol. 54, 19\u201348 (2000).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFnm1475_CR19","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1182\/blood-2003-12-4287","volume":"103","author":"HJ Wagner","year":"2004","unstructured":"Wagner, H.J. et al. Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood 103, 3979\u20133981 (2004).","journal-title":"Blood"},{"key":"BFnm1475_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.1980.tb27955.x","volume":"354","author":"G Wadell","year":"1980","unstructured":"Wadell, G., Hammarskjold, M-L., Winberg, G., Varsanyi, T.W. & Sundell, G. The genetic variability of adenoviruses. Ann. NY Acad. Sci. 354, 16\u201342 (1980).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnm1475_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1182\/blood-2003-07-2449","volume":"103","author":"AM Leen","year":"2004","unstructured":"Leen, A.M. et al. Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 103, 1011\u20131019 (2004).","journal-title":"Blood"},{"key":"BFnm1475_CR22","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1089\/hum.1998.9.10-1419","volume":"9","author":"CA Smith","year":"1998","unstructured":"Smith, C.A., Woodruff, L.S., Rooney, C. & Kitchingman, G.R. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Hum. Gene Ther. 9, 1419\u20131427 (1998).","journal-title":"Hum. Gene Ther."},{"key":"BFnm1475_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1182\/blood.V97.4.835","volume":"97","author":"S Gottschalk","year":"2001","unstructured":"Gottschalk, S. et al. An Epstein-Barr virus deletion mutant that causes fatal lymphoproliferative disease unresponsive to virus-specific T cell therapy. Blood 97, 835\u2013843 (2001).","journal-title":"Blood"},{"key":"BFnm1475_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1099\/0022-1317-76-1-139","volume":"76","author":"P Busson","year":"1995","unstructured":"Busson, P., Edwards, R.H., Tursz, T. & Raab-Traub, N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 76, 139\u2013145 (1995).","journal-title":"J. Gen. Virol."},{"key":"BFnm1475_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1084\/jem.20040890","volume":"200","author":"CM Bollard","year":"2004","unstructured":"Bollard, C.M. et al. Cytotoxic T lymphocyte therapy for Epstein-Barr virus + Hodgkin's Disease. J. Exp. Med. 200, 1623\u20131633 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnm1475_CR26","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20042384","volume":"201","author":"T Bunde","year":"2005","unstructured":"Bunde, T. et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201, 1031\u20131036 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnm1475_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4615-0757-4_22","volume":"512","author":"EJ Wherry","year":"2002","unstructured":"Wherry, E.J. et al. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15R\u03b1. Adv. Exp. Med. Biol. 512, 165\u2013175 (2002).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnm1475_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","volume":"36","author":"GD Myers","year":"2005","unstructured":"Myers, G.D. et al. Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath). Bone Marrow Transplant. 36, 1001\u20131008 (2005).","journal-title":"Bone Marrow Transplant."},{"key":"BFnm1475_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00002371-200305000-00008","volume":"26","author":"U Sili","year":"2003","unstructured":"Sili, U. et al. Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocytes using lymphoblastoid cell lines for adoptive immunotherapy. J. Immunother. 26, 241\u2013256 (2003).","journal-title":"J. Immunother."},{"key":"BFnm1475_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/sj.gt.3301488","volume":"8","author":"P Yotnda","year":"2001","unstructured":"Yotnda, P. et al. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 8, 930\u2013937 (2001).","journal-title":"Gene Ther."},{"key":"BFnm1475_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","volume":"345","author":"CM Rooney","year":"1995","unstructured":"Rooney, C.M. et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet 345, 9\u201313 (1995).","journal-title":"Lancet"},{"key":"BFnm1475_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/jmv.10382","volume":"70","author":"A Heim","year":"2003","unstructured":"Heim, A., Ebnet, C., Harste, G. & Pring-Akerblom, P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J. Med. Virol. 70, 228\u2013239 (2003).","journal-title":"J. Med. Virol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm1475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1475","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm1475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T05:22:29Z","timestamp":1659158549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,24]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["BFnm1475"],"URL":"https:\/\/doi.org\/10.1038\/nm1475","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1046547.496528","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,24]]},"assertion":[{"value":"3 April 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}